Search clinical trials for: Triple-hit DLBCL
Total 574 results
-
Fudan UniversityRecruitingDiffuse Large B Cell Lymphoma, Gene MutationChina
-
Ruijin HospitalNot yet recruitingLymphoma, Large B-Cell, Diffuse | Chemotherapy | TransplantationChina
-
Huiqiang HuangRecruitingHigh-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Non-GCB/ABC Diffuse Large B-Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
Miltenyi Biomedicine GmbHRecruitingCentral Nervous System Lymphoma | Transformed Lymphoma | Refractory Diffuse Large B Cell Lymphoma (DLBCL) | Primary Mediastinal B-cell Lymphoma (PMBCL) | High Grade B-cell Lymphoma (HGBCL) | Relapsed Diffuse Large B Cell LymphomaUnited States
-
Ruijin HospitalRecruitingLymphoma, Large B-Cell, Diffuse | Chemotherapy | TransplantationChina
-
Bambino Gesù Hospital and Research InstituteRecruitingAcute Lymphoblastic Leukemia | Diffuse Large B Cell Lymphoma | Primary Mediastinal LymphomaItaly
-
Huazhong University of Science and TechnologyShanghai IASO Biotechnology Co., LtdNot yet recruitingChronic Lymphocytic Leukemia (CLL) | Peripheral T-cell Lymphomas (PTCL) | CD5+ Relapsed/Refractory Hematopoietic Malignancies | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL)
-
Ruijin HospitalRecruitingPrimary Mediastinal Large B Cell Lymphoma | EBV-Positive DLBCL, NosChina
-
Qian WenbinNot yet recruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaChina
-
Guangdong Provincial People's HospitalGuangzhou First People's Hospital; Foshan First People's Hospital; Huizhou Municipal... and other collaboratorsRecruitingDiffuse Large B Cell Lymphoma | Age Over 80 YearsChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingDiffuse Large B-cell LymphomaChina
-
Swiss Group for Clinical Cancer ResearchRecruitingDiffuse Large B-cell LymphomaSwitzerland, Italy
-
University of Texas Southwestern Medical CenterRecruiting
-
University of RochesterGenentech, Inc.RecruitingLymphoma, B-Cell | DLBCLUnited States
-
AstraZenecaRecruitingFollicular Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | B-cell Non Hodgkin LymphomaKorea, Republic of, United States, Japan, Taiwan, Australia
-
University Hospital Southampton NHS Foundation...AstraZenecaRecruitingDiffuse Large B Cell LymphomaUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterActinium PharmaceuticalsRecruitingDiffuse Large B-cell Lymphoma | B-ALL | DLBCL | DLBCL, Nos Genetic Subtypes | B ALL | Dlbcl-Ci | DLBCL Unclassifiable | DLBCL Activated B-Cell Type | DLBCL Germinal Center B-Cell Type | HGBL | HGBL, NosUnited States
-
Kartos Therapeutics, Inc.RecruitingChronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaBelgium, Korea, Republic of, United States, United Kingdom, Italy, Switzerland, Australia, France, Poland, Portugal, Czechia
-
Huiqiang HuangRecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
Karyopharm Therapeutics IncRecruitingRelapsed/Refractory Diffuse Large B-cell LymphomaUnited States, Spain, Israel, Italy, Poland, China, Austria
-
The First Affiliated Hospital with Nanjing Medical...RecruitingDLBCL | Untreated | MYC Gene RearrangementChina
-
Nordic Lymphoma GroupRoche Pharma AGRecruitingDiffuse Large B Cell Lymphoma | DLBCLFinland, Norway, Denmark, Italy, Sweden, Australia, New Zealand
-
AVM Biotechnology IncMedpace, Inc.RecruitingLymphoid MalignanciesUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Lymphoma, B-Cell | Multiple Myeloma | High-grade B-cell Lymphoma | Refractory B-Cell Lymphoma | DLBCL NOSUnited States
-
Istituto Scientifico Romagnolo per lo Studio e...RecruitingDiffuse Large B Cell LymphomaItaly
-
Cambridge University Hospitals NHS Foundation TrustAstraZeneca; Cancer Research UK Cambridge InstituteRecruitingHigh-grade B-cell LymphomaUnited Kingdom
-
Fujian Medical UniversityRecruitingRelapsed or Refractory DLBCL Patients With Either CD19 or CD20 PositiveChina
-
The First Affiliated Hospital with Nanjing Medical...RecruitingEBV-Positive DLBCL, NosChina
-
Centre Hospitalier Universitaire, AmiensInstitut Bergonié; Centre Henri Becquerel; Saint-Louis Hospital, Paris, France; Henri Mondor University Hospital and other collaboratorsRecruitingChemotherapy | Elderly | Diffuse Large B-Cell Lymphoma (DLBCL), NosFrance
-
Bio-Path Holdings, Inc.RecruitingFollicular Lymphoma | Hodgkin Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | DLBCL | Cutaneous T-cell Lymphoma (CTCL) | Peripheral T-cell Lymphoma (PTCL)United States
-
Huiqiang HuangRecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
Malaghan Institute of Medical ResearchWellington Zhaotai Therapies Limited (WZTL)RecruitingMantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)New Zealand
-
Sun Yat-sen UniversityRecruitingLymphoma, Large B-Cell, DiffuseChina
-
National Cancer Institute (NCI)RecruitingDiffuse Large B-Cell Lymphoma | Non-Hodgkin's Lymphoma | NHL | DLBCLUnited States
-
University of ChicagoMerck Sharp & Dohme LLCRecruitingLymphoma | Diffuse Large B Cell LymphomaUnited States
-
University Hospital, LimogesRecruitingLymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL)France
-
Novartis PharmaceuticalsRecruitingAcute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Small Lymphocytic Lymphoma | Large B-cell LymphomaJapan, Australia, Germany, Italy, Spain, France, Austria, United States
-
Sun Yat-sen UniversityRecruitingLymphoma, Non-Hodgkin | Pediatric Cancer | RituximabChina
-
University of Wisconsin, MadisonMedical College of WisconsinRecruitingCancer | Diffuse Large B Cell Lymphoma | DLBCLUnited States
-
Xynomic Pharmaceuticals, Inc.RecruitingDiffuse Large B-cell Lymphoma (DLBCL)China
-
Regeneron PharmaceuticalsRecruitingB-cell Non-Hodgkin Lymphoma (NHL)United States, Korea, Republic of, China, Spain, Japan, United Kingdom, France, Taiwan, Singapore, Italy, Australia, Canada, Germany, Poland
-
Hospices Civils de LyonThe Lymphoma Academic Research OrganisationRecruitingMantle Cell Lymphoma (MCL) | Follicular Lymphoma (FL) | Diffuse Large B Lymphoma (DLBCL) | Marginal Zone Lymphoma (MZL) | T-cell Lymphoma (T-NHL) | Hodgkin's Lymphoma (HL) | Burkitt Lymphoma (BL))France
-
University of RochesterRecruiting
-
Swedish Medical CenterAcerta Pharma BVRecruiting
-
Fondazione Italiana Linfomi - ETSJanssen-Cilag S.p.A.Recruiting
-
MEI Pharma, Inc.RecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Acute Myeloid Leukemia (AML) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone Lymphoma (MZL)United States
-
First Affiliated Hospital of Harbin Medical UniversityRecruiting
-
Stichting Hemato-Oncologie voor Volwassenen NederlandRecruiting
-
Curis, Inc.RecruitingRelapsed Primary Central Nervous System Lymphoma | Refractory Hematologic Malignancy | Relapsed Hematologic Malignancy | Refractory Primary Central Nervous System LymphomaUnited States, Spain, France, Czechia, Israel, Italy, Poland